3/A

OWNERSHIP DOCUMENT

Company: Phathom Pharmaceuticals, Inc.
Filed: February 6, 2020
Period of Report: February 6, 2020
Accession Number: 0001104659-20-012009

View Document ↗ View on SEC.gov ↗